David Abrams · Q4 2020
Abrams Capital Management
Portfolio at the end of Q4 2020, from the 13F filed February 12, 2021. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Lithia Motors LAD · history | 19.4% | Q2 2018 | Add 6% |
| TransDigm TDG · history | 9.4% | Q1 2020 | No change |
| Meta Platforms META · history | 9.3% | Q4 2018 | No change |
| Asbury Automotive ABG · history | 8.7% | Q3 2017 | No change |
| PG&E PCG · history | 8.2% | Q1 2019 | Reduce 7% |
| Alphabet GOOGL · history | 7.2% | Q2 2018 | No change |
| U-Haul Holding UHAL · history | 7.2% | Q4 2016 | No change |
| Teva TEVA · history | 6.5% | Q3 2017 | No change |
| Willis Towers Watson WTW · history | 6.5% | Q4 2016 | No change |
| Kinder Morgan KMI · history | 4.8% | Q1 2018 | No change |
| Energy Transfer ET · history | 3.9% | Q1 2020 | No change |
| Camping World CWH · history | 3.8% | Q3 2018 | No change |
| O-I Glass OI · history | 2.3% | Q4 2019 | No change |
| TransMedics Group TMDX · history | 2.0% | Q2 2019 | No change |
| Bristol-Myers Squibb BMY.RT · rights · history | 0.5% | Q4 2019 | Add 68% |
| Sculptor Capital SCU · history | 0.2% | Q3 2019 | Reduce 67% |
| Clear Channel Outdoor CCO · history | 0.2% | Q2 2013 or earlier | No change |
| 17 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2020, adjusted for stock splits.
Sector weighting
| Consumer discretionary | 31.9% | |
|---|---|---|
| Industrials | 16.6% | |
| Technology | 16.5% | |
| Health care | 9.0% | |
| Energy | 8.7% | |
| Utilities | 8.2% | |
| Financials & real estate | 6.7% | |
| Materials | 2.3% | |
| Media & telecom | 0.2% |
What changed from Q3 2020
- Add 6% Lithia Motors LAD 16.0% → 19.4%
- Add 68% Bristol-Myers Squibb BMY.RT 1.1% → 0.5%
- Reduce 7% PG&E PCG 7.4% → 8.2%
- Reduce 67% Sculptor Capital SCU 0.6% → 0.2%
- Sell Franklin Resources BEN was 5.3%
- Sell Akebia Therapeutics AKBA was 0.4%